
CAS 356068-99-0
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Sunitinib N-Oxide ((Z)-N,N-diethyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)ethan-1-amine oxide)
CAS:Lactams, nesoiFormula:C22H27FN4O3Color and Shape:Yellow Orange SolidMolecular weight:414.20672Sunitinib N-Oxide
CAS:<p>Stability Hygroscopic<br>Applications Sunitinib N-Oxide, is a derivative of Sunitinib (S820000), a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK), used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor. It is a COVID19-related research product.<br>References Sun, L., et al.: J. Med. Chem., 46, 1116 (2003), Mendel, D.B., et al.: Clin. Cancer Res., 9, 327 (2003), Sistla, A., et al.: Drug Dev. Ind. Pharm., 30, 19 (2004), Sakamoto, K.M., et al.: Curr. Opin. Invest. Drugs, 5. 1329 (2004),<br></p>Formula:C22H27FN4O3Color and Shape:NeatMolecular weight:414.47Sunitinib N-Oxide-d10
CAS:Controlled ProductFormula:C22D10H17FN4O3Color and Shape:NeatMolecular weight:424.535Sunitinib N-oxide
CAS:<p>Sunitinib N-oxide is the active form of sunitinib, a drug that is used to treat cancer. Sunitinib N-oxide is a photolabile n-oxide and can be converted to sunitinib by exposure to light. This conversion process can be used as an analytical technique for determining the concentration of the drug in blood or tissue samples. Sunitinib N-oxide has been shown to reduce tumor growth in mouse models and also inhibits angiogenesis and tumor metastasis. The drug has also been shown to have anti-inflammatory effects, which may be due to its inhibition of prostaglandin synthesis.</p>Formula:C22H27FN4O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:414.47 g/mol






